We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
ESTRO
Menu
  • Corporate Members
  • E-Library
  • Twitter
  • Linked In
  • Facebook
  • Instagram
  • Join
  • MyESTRO
Search Opener
  • About ESTRO
  • Membership
  • School
  • Workshops
  • Congresses
  • Science
  • Education
  • Advocacy
  • Corporate Members
  • E-Library
  1. Home
  2. About ESTRO
  3. Newsroom
  4. Newsletter
  5. Conferences

Achieve recognition of all radiotherapy professions

Conferences
  • 11/07/2025

    Lower GI Spotlight at ESTRO 2025: Trials, Trends, and Treatment Shifts

  • 10/07/2025

    Ultra-hypofractionated Radiotherapy for Localised Prostate Cancer: 10-Year Outcomes of the HYPO-RT-PC Phase 3 Trial

  • 08/07/2025

    Best paper award - Interdisciplinary: Advancing the ESTRO-HERO cost tool for innovative treatment costing and flexible resource allocation

  • 07/07/2025

    The 17th European Multidisciplinary Congress on Urological Cancers (EMUC25)

  • 03/07/2025

    CBCT vs. MR: Which will lead the future of online adaptive radiotherapy? Positioning & Immobilisation

  • 01/07/2025

    Factors influencing locoregional recurrence rates in rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial

News Pages: 1 2 3 4 5 6 7 8 9 10
  • Newsletter 2019
  • Newsletter 2018
  • Newsletter 2017
  • Contact
  • Privacy Statement
  • Sitemap
  • Careers
  • FAQ
  • Twitter
  • Linked In
  • Facebook
  • Instagram

© The European SocieTy for Radiotherapy and Oncology. All rights reserved. ESTRO Avenue Marnix 17, 1000 Brussels . +32 477 271 125.